Randomized trial evaluates receptor binding and viral fitness of A(H5N1) with E190D substitution in ferrets, suggesting lower public health risk.
The detection of a clade 2.3.4.4b influenza A(H5N1) virus bearing an HA-E190D substitution in an infected human raises concern about mammalian adaptation. We evaluated the impact of the naturally occurring HA-E190D substitution in the A/British Columbia/PHL-2032/2024 (BC/24) virus on receptor binding specificity and viral fitness in vitro and in vivo. Recombinant BC/24 HA-E190D protein retained α2,3-linked sialic acid binding specificity but with reduced binding affinity. In cell culture, BC/24 viruses dominated by HA-190D were frequently outcompeted by the minor HA-190E variant in the inoculum, whereas BC/24 HA-190E viruses maintained dominance in the presence of residual HA-190D in the inoculum. In ferrets, BC/24 HA-190D viruses were similarly outcompeted by HA-190E; in one out of six ferrets where HA-190D dominance persisted, the virus was attenuated and failed to spread systemically. In contrast, BC/24 HA-190E viruses maintained dominance and disseminated systemically. These results indicate that the BC/24 variant bearing HA-E190D substitution did not acquire human-like receptor binding specificity and was less fit in mammalian hosts, making it unlikely to enhance public health risk without additional compensatory mutations.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: